You are viewing an incomplete version of our website. Please click to reload the website as full version.

HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (AA 61-83) antibody

Details for Product No. ABIN192401, Supplier: Log in to see
Antigen
  • B-F
  • B-F-S04
  • B-F-S05
  • B-F-S06
  • B-F-S07
  • B-FI
  • B-FIV
  • BF2
  • BFa2
  • BFw-03
  • BFw-05
  • BFz-01
  • MHC-G
Epitope
AA 61-83
73
17
8
8
7
7
7
6
6
5
3
2
2
2
1
1
1
1
1
Reactivity
Human
506
8
6
3
1
Host
Mouse
410
72
26
6
3
1
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
52
50
37
28
13
9
9
9
9
9
9
9
9
9
9
9
8
8
8
5
1
1
1
1
1
1
Application
Immunocytochemistry (ICC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), ELISA, Western Blotting (WB)
309
294
276
148
147
146
116
107
81
19
19
18
7
2
2
1
1
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Immunogen amino acids 61-83 of HLA-G of human origin
Clone 4H84
Isotype IgG1
Specificity The antibody 4H84 recognizes HLA-G molecule (39 kDa). HLA-G belongs to the MHC Class I molecules (MHC Class Ib, nonclassical) and it is expressed on the surface of trophoblast cells.This product is for research and in vitro experimental use only. It is not to be used for any other commercial purpose. Use of this product to produce products for sale or for therapeutic or drug discovery purposes is prohibited. In order to obtain a license to use this product for commercial purposes, contact The Regents of the Univessity of California.
Purification Purified from hybridoma culture supernatant by protein-A affinity chromatography.
Purity > 95 % (by SDS-PAGE)
Alternative Name HLA-G (HLAG Antibody Abstract)
Research Area Major Histocompatibility Complex (MHC)
Application Notes Immunohistochemistry (paraffin sections) Recommended dilution: 10 µg/mL
ELISA:
Application note: The antibody 4H84 has been tested as the capture antibody in a sandwich ELISA for analysis of heavy chains of all HLA-G isoforms in combination with antibody MEM-G/1 .

Working concentrations should be determined by the investigator.
Restrictions For Research Use only
Concentration 1 mg/mL
Buffer Phosphate buffered saline (PBS) with 15 mM sodium azide, approx. pH 7.4
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handling Advice Do not freeze.
Storage 4 °C
Storage Comment Store at 2-8 °C. Do not use after expiration date stamped on vial label.
Supplier Images
 image for anti-HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG) (AA 61-83) antibody (ABIN192401) Immunoprecipitation of HLA-G from HLA-G1 transfectants (LCL-HLA-G1) by MEM-G/9 antibo...
Product cited in: Schumann, Buck, Classen-Linke, Wennemuth, Grümmer: "Claudin-3, claudin-7, and claudin-10 show different distribution patterns during decidualization and trophoblast invasion in mouse and human." in: Histochemistry and cell biology, Vol. 144, Issue 6, pp. 571-85, 2015 (PubMed).

Guo, Chen, Ruan, Lin, Yan: "HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia." in: Leukemia research, 2011 (PubMed). (1:1000).

Barrier, Kendall, Sharpe-Timms, Kost: "Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma." in: Gynecologic oncology, Vol. 103, Issue 1, pp. 25-30, 2006 (PubMed).

Gonen-Gross, Achdout, Arnon, Gazit, Stern, Horejsí, Goldman-Wohl, Yagel, Mandelboim: "The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and beta 2-microglobulin-free HLA-G molecules." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 175, Issue 8, pp. 4866-74, 2005 (PubMed).

Juch, Blaschitz, Daxböck, Rueckert, Kofler, Dohr: "A novel sandwich ELISA for alpha1 domain based detection of soluble HLA-G heavy chains." in: Journal of immunological methods, Vol. 307, Issue 1-2, pp. 96-106, 2005 (PubMed).

Poláková, Kuba, Russ: "The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes." in: Human immunology, Vol. 65, Issue 2, pp. 157-62, 2004 (PubMed).

Menier, Saez, Horejsi, Martinozzi, Krawice-Radanne, Bruel, Le Danff, Reboul, Hilgert, Rabreau, Larrad, Pla, Carosella, Rouas-Freiss: "Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules." in: Human immunology, Vol. 64, Issue 3, pp. 315-26, 2003 (PubMed).

Poláková, Krcová, Kuba, Russ: "Analysis of HLA-G expression in malignant hematopoetic cells from leukemia patients." in: Leukemia research, Vol. 27, Issue 7, pp. 643-8, 2003 (PubMed).

Blaschitz, Hutter, Dohr: "HLA Class I protein expression in the human placenta." in: Early pregnancy (Online), Vol. 5, Issue 1, pp. 67-9, 2001 (PubMed).

Paul, Rouas-Freiss, Khalil-Daher, Moreau, Riteau, Le Gal, Avril, Dausset, Guillet, Carosella: "HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 95, Issue 8, pp. 4510-5, 1998 (PubMed).

Reference: Zheng, Wang, Zhang, Du, Zhang, Kan, Zhu, Dong, Wang, Wang, Li: "Up-regulation of HLA-G expression in cervical premalignant and malignant lesions." in: Tissue antigens, Vol. 77, Issue 3, pp. 218-24, 2011 (PubMed).

Gonen-Gross, Goldman-Wohl, Huppertz, Lankry, Greenfield, Natanson-Yaron, Hamani, Gilad, Yagel, Mandelboim: "Inhibitory NK receptor recognition of HLA-G: regulation by contact residues and by cell specific expression at the fetal-maternal interface." in: PLoS ONE, Vol. 5, Issue 1, pp. e8941, 2010 (PubMed).

Gan, Huang, Zhang, Lin, Xu, Wang, Wang, Yan: "Tumor-specific upregulation of human leukocyte antigen-G expression in bladder transitional cell carcinoma." in: Human immunology, 2010 (PubMed).

Urosevic, Kurrer, Kamarashev, Mueller, Weder, Burg, Stahel, Dummer, Trojan: "Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production." in: The American journal of pathology, Vol. 159, Issue 3, pp. 817-24, 2001 (PubMed).